Research / VIVS / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-25-082312 General Corporate
Capex intensity 30th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
9.03% · OPTIONAL · VALID
Operating cash generation 60th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-6570.14% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
32.11% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
96.53% · CORE · NOT_ENOUGH_HISTORY
Operating margin 30th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
-8761.11% · CORE · VALID
R&D intensity 60th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3489.58% · OPTIONAL · VALID
SBC intensity 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
369.44% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 12 states History building
Mar 31, 2023 0/6 normalized Level 3 Dec 31, 2023 0/6 normalized Level 3 Mar 31, 2024 0/7 normalized Level 3 Jun 30, 2024 0/8 normalized Level 3 Sep 30, 2024 5/7 normalized Level 3 Dec 31, 2024 5/8 normalized Level 3 Mar 31, 2025 5/8 normalized Level 3 Jun 30, 2025 4/6 normalized Level 3 Sep 30, 2025 5/6 normalized Level 3 Dec 31, 2025 6/7 normalized Level 3 Mar 31, 2026 6/7 normalized Level 3 Jun 30, 2026 6/6 normalized Level 3 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.00%
Current 9.03%
Delta 9.03% Cash Generation Increased
Previous -7504.17%
Current -6570.14%
Delta 934.03% Growth Decreased
Previous 380.00%
Current 32.11%
Delta -347.89% Margin Increased
Previous 91.67%
Current 96.53%
Delta 4.86% Profitability Increased
Previous -14450.00%
Current -8761.11%
Delta 5688.89% R And D Intensity Decreased
Previous 7416.67%
Current 3489.58%
Delta -3927.08% Sbc Intensity Decreased
Previous 541.67%
Current 369.44%
Delta -172.22% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.